In today's episode, we're joined by Carles Garcia-Vitoria, a seasoned pain physician with a unique approach to his work. With extensive experience in regional anesthesia and pain management, Carles shares insights gained from his years of practical experience as he pursues his PhD in Spain.

 Top 3 Takeaways:

• "We believe we have the opportunity to target the site of action more effectively. That's why we've founded Spinally, the startup we're currently leading. Our goal is to pioneer intrathecal spinal cord stimulation."
• "The Dura Mater is highly elastic, closing approximately 80-90% within the first 30 seconds after trauma. Additionally, with improved intrathecal access and emission capabilities, we can utilize thinner implants—reducing implant thickness from 1.3 to 0.5 millimeters. This minimizes trauma to the meningeal sac even further."
• "We can leverage new fabrication capabilities to minimize implants and achieve highly effective pain relief. Our models, along with others, indicate that we can stimulate deeper layers of the spinal cord with intrathecal electrode positioning, enhancing our ability to listen to deeper neuronal tracts. This advancement is poised to make significant waves in the pain management field within a year."

0:45 Can you introduce yourself better than I just did?

1:15 What advantages of neurotechnology do you see in the pain market?

 3:15 What does the pain treatment process using neuromodulation look like?

6:45 How is closed loop stimulation changing your work?

8:30 You’re involved in a startup to better listen to the spinal cord, can you talk about that?

11:30 Why hasn’t this been done before?

14:00 Where in the startup process are you?

15:30 Where are you getting the leads from?

16:30 You guys are raising money, can you talk about that?

18:30 Crowdfunding for medical devices is new, have you seen these before?

21:00 Is there anything that we didn’t cover that you wanted to mention?